耐火性纯红细胞无形成症与T细胞大粒状淋巴细胞白血病相关,由ruxolitinib治疗

Yuemin Gong1, Yue Li1, Xiaoyu Chen1

  • 1Department of Hematology, Jiangsu Province Hospital, Key Laboratory of Hematology, Collaborative Innovation Center for Cancer Personalized Medicine, The First Affiliated Hospital, Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210000, China.

Annals of hematology
|June 27, 2024
PubMed
概括

与T细胞大颗粒性淋巴细胞 (T-LGL) 白血病相关的耐火性获得的纯红细胞无形成症 (PRCA) 可以通过ruxolitinib有效治疗. 这种JAK抑制剂导致了对其他疗法的耐药性患者的完全缓解.